Abstract
Comparative proteomic analysis of normal and cancer cell lines provides for a better understanding of the molecular mechanism of cancer development and is essential for developing more effective strategies for new biomarker or drug target discovery. The purpose of this study is to compare protein expression levels between fibrosarcoma and fibroblast cell lines. In our study, two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) and liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) techniques were carried out to compare the protein profile between fibrosarcoma and fibroblast cell lines. We prepared cell lysate samples to analyze intracellular proteins and secretome samples to analyze extracellular proteins in both cell lines. Our results revealed 13 upregulated proteins and 1 downregulated protein of which all of them identified in fibrosarcoma cell line after the comparison with fibroblast cell line cell lysates. When comparing secretome profiles of both cell lines, we found and identified 13 proteins only expressed in fibrosarcoma cell line. These identified proteins have common functions such as cell proliferation, cell differentiation, invasion, metastasis, and apoptosis in cancer. The data obtained from this study indicates that these proteins have importance on understanding the molecular mechanism of fibrosarcoma. These proteins may serve as candidate biomarkers and drug targets for future clinical studies.
Similar content being viewed by others
References
Fletcher CDM, Krishnan Unni K, Mertens F. Pathology and genetics of tumours of soft tissue and bone. 3rd ed. Lyon: IARC; 2006.
Nikitovic D, Kouvidi K, Karamanos NK, Tzanakakis GN. The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression. Biomed Res Int. 2013;2013:929531.
Hajdu SI. Fibrosarcoma: a historic commentary. Cancer. 1998;82:2081–9.
Goldblum JR, Folpe AL, Weiss SW. Enzinger and Weiss’s soft tissue tumors. 6th ed. Philadelphia: Elsevier Saunders; 2013.
Song B, Kim B, Choi SH, Song KY, Chung YG, Lee YS, et al. Mesenchymal stromal cells promote tumor progression in fibrosarcoma and gastric cancer cells. Korean J Pathol. 2014;48(3):217–24.
Klijanienko J, Lagace R. Soft tissue tumors: a multidisciplinary, decisional diagnostic approach. 1st ed. Hoboken: Wiley; 2011.
Xue H, Lu B, Lai M. The cancer secretome: a reservoir of biomarkers. J Transl Med. 2008;6:52.
Zwickl H, Traxler E, Staettner S, Parzefall W, Grasl-Kraupp B, Karner J, et al. A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis. 2005;26:2779–85.
Guoqing L, Zhefeng X, Jianping L, Cui L, Feng L, Zhuchu C. Cancer: a proteomic disease. Sci China Life Sci. 2011;54:403–8.
Rubporn A, Srisomsap C, Subhasitanont P, Chokchamnankit D, Chiablaem K, Svasti J, et al. Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line. Cancer Genomics Proteomics. 2009;6:229–37.
Zang J, Wang P, Gao S, Xiao D, Zhang J, Wang K. Differential proteins expression between gastric cancer and normal cell lines. Life Sci J. 2008;5(4):28–32.
Deng SS, Xing TY, Zhou HY, Xiong RH, Lu YG, Wen B, et al. Comparative proteome analysis of breast cancer and adjacent normal breast tissues in human. Genomics Proteomics Bioinforma. 2006;4(3):165–72.
Johansson B, Pourian MR, Chuan Y, Byman I, Bergh A, Pang ST, et al. Proteomic comparison of prostate cancer cell lines LNCaP-FGC and LNCaP-r reveals heatshock protein 60 as a marker for prostate malignancy. Prostate. 2006;66:1235–44.
Antharavally BS, Mallia KA, Rangaraj P, Haney P, Bell PA. Quantitation of proteins using a dye-metal-based colorimetric protein assay. Anal Biochem. 2009;385(2):342–5.
Shen H, Huang J, Pei H, Zeng S, Tao Y, Shen L, et al. Comparative proteomic study for profiling differentially expressed proteins between chinese left and right sided colon cancers. Cancer Sci. 2013;104(1):135–41.
Yang MS, Wang HS, Wang BS, Li WH, Pang ZF, Zou BK, et al. A comparative proteomic study identified calreticulin and prohibitin up-regulated in adenocortical carcinomas. Diagn Pathol. 2013;8:58.
Coghlin C, Carpenter B, Dundas SR, Lawrie LC, Telfer C, Murray GI. Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer. J Pathol. 2006;210:351–57.
Li C, Chen Z, Xiao Z, Wu X, Zhan X, Zhang X, et al. Comparative proteomic analysis of human lung squamous carcinoma. Biochem Biophys Res Commun. 2003;309:253–60.
Wang TH, Chao A, Tsai CL, Chang CL, Chen SH, Lee YS, et al. Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics. 2010;9(9):1873–84.
Chang HY, Hor SY, Lim KP, Zain RB, Cheong SC, Rahman MA, et al. Oral cancer secretome: identification of cancer associated proteins. Electrophoresis. 2013;34(15):2199–208.
Dos Santos M, Da Cunha Mercante AM, Nunes FD, Leopoldino AM, De Carvalho MB, Gazito D, et al. Prognostic significance of ndrg1 expression in oral and oropharyngeal squamous cell carcinoma. Mol Biol Rep. 2012;39(12):10157–65.
Pino I, Pio R, Toledo G, Zabalegui N, Vicent S, Rey N, et al. Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer. 2003;41(2):131–43.
Chaker S, Kashat L, Voisin S, Kaur J, Kak I, Macmillan C, et al. Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas. Proteomics. 2013;13(5):771–87.
Ito K, Stannard K, Gabutero E, Clark AM, Neo SY, Onturk S, et al. Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment. Cancer Metastasis Rev. 2012;31:763–78.
Yin J, Chen G, Liu Y, Liu S, Wang P, Wan Y, et al. Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival. J Exp Clin Cancer Res. 2010;29:59.
Kaneko T, Konno H, Baba M, Tanaka T, Nakamura S. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. Cancer Sci. 2003;94(1):43–9.
Ge S, Mao Y, Yi Y, Xie D, Chen Z, Xiao Z. Comparative proteomic analysis of secreted proteins from nasopharyngeal carcinoma-associated stromal fibroblasts and normal fibroblast. Exp Ther Med. 2012;3:857–60.
Sardana G, Marshall J, Diamandis EP. Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture conditioned medium. Clin Chem. 2007;53(3):429–37.
Sasaki T, Hankins GR, Helm GA. Major vault protein/lung resistance-related protein (MVP/LRP) expression in nervous system tumors. Brain Tumor Pathol. 2002;19(2):59–62.
Diaz-Ramos A, Roig-Borrellas A, Garcia-Melero A, Lopez-Alemany R. α-Enolase, a multifunctional protein: its role on pathophysiological situations. J Biomed Biotechnol. 2012;2012:156795.
Acknowledgments
The authors thank Dr. Tarik Baykal from Medipol University for the assistance with LC-MS/MS analysis and Dr. Mert Pekcan from Ankara University for providing technical assistance and suggestions. This study was supported by Ankara University Scientific Research Grant (grant no. 12B3338001).
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meral, O., Uysal, H. Comparative proteomic analysis of fibrosarcoma and skin fibroblast cell lines. Tumor Biol. 36, 561–567 (2015). https://doi.org/10.1007/s13277-014-2672-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-014-2672-8